Robuta

https://research.utwente.nl/en/publications/2417p-de-escalation-of-therapy-with-androgen-receptor-pathway-inh/ 2417P De-escalation of therapy with androgen receptor pathway inhibitors or docetaxel by using PSMA... androgen receptordeescalationtherapypathway https://www.antoniusziekenhuis.nl/behandelingen-onderzoeken/lutetium-psma-therapie-bij-de-behandeling-van-prostaatkanker Lutetium-PSMA therapie bij de behandeling van prostaatkanker | St. Antonius Ziekenhuis Als hormoon- en chemotherapie niet meer werken bij de behandeling van prostaatkanker, kan therapie met lutetium-PSMA een mogelijkheid zijn. de behandelinglutetiumpsmatherapiebij https://pharsight.greyb.com/therapeutics/psma-positive-prostate-cancer-imaging Drug Therapeutics of Psma Positive Prostate Cancer Imaging A detailed list of the drug therapeutics of Psma Positive Prostate Cancer Imaging, along with the patent title, drug patent expiry date, ingredients,... prostate cancerdrugtherapeuticspsmapositive https://www.vidal.fr/medicaments/gammes/psma-11-78645.html PSMA-11 psma https://rx.news/psma-targeted-radioligand-therapy-doubles-progression-free-survival-in-recurrent-prostate-cancer-phase-2-trial-shows/ PSMA-Targeted Radioligand Therapy Doubles Progression-Free Survival in Recurrent Prostate Cancer,... Oct 6, 2025 - This trial represents a crucial proof-of-principle for earlier intervention with radioligand therapy, potentially transforming the treatment paradigm fo... recurrent prostate cancerpsmatargetedtherapydoubles https://dev.iss-foundation.org/tuna-stocks-and-management/fisheries-management/regional-fisheries-management-organizations-rfmos/participation-in-tuna-rfmos-unfsa-and-psma/ Participation in Tuna RFMOs, UNFSA and PSMA - International Seafood Sustainability Foundation Jul 15, 2025 - Based on where it has tuna-fishing interests, a country can apply to join, and follow the regulations of, a tuna Regional Fisheries Management Organization... seafood sustainabilityparticipationtunapsmainternational https://connect.uclahealth.org/dom/tag/psma-pet-ct/ PSMA PET/CT | Department of Medicine Blog PSMA PET/CT archive. department of medicinepsma petctblog https://pmc.ncbi.nlm.nih.gov/articles/PMC8612346/ PSMA Expression Assessed by PET Imaging Is a Required Biomarker for Selecting Patients for Any... by petis apsmaexpressionassessed https://open.uni-marburg.de/entities/thesis/2d64744d-2b1c-45b9-9840-f088d9b3c823 Untersuchung zum Diagnostischen Impact einer Dual-time-PET/CT mit PSMA-Liganden beim... In der vorliegenden Arbeit wurde mittels retrospektiver Datenanalyse der diagnostische Impact der Dual-time PET/CT-Untersuchungen mit Ga 68-DOTATOC bei... dual timepet ctuntersuchungzumimpact https://www.survivornet.com/clinical-trials/prostate-cancer/maximizing-responses-to-anti-pd1-immunotherapy-with-psma-targeted-alpha-therapy-in-mcrpc/ Prostate Cancer Clinical Trial: Maximizing Responses to Anti-PD1 Immunotherapy With PSMA-targeted... Nov 13, 2023 - Prostate Cancer - Phase I/II Trial of Pembrolizumab and Androgen-receptor Pathway Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration... prostate cancerclinical trialresponsesantiimmunotherapy https://www.siemens-healthineers.com/at/molecular-imaging/mi-clinical-corner/scientific-presentations/jackson Radiation dosimetry in 177 Lu-PSMA-617 therapy using a single post-treatment SPECT/CT scan Dr. Price Jackson, Peter MacCallum Cancer Centre, Melbourne, Australia radiation dosimetrysingle postct scanlupsma https://biopharmaapac.com/news/79/5047/fda-accepts-telixs-nda-for-tlx007-cdx-expanding-psma-pet-imaging-access.html FDA Accepts Telix's NDA for TLX007-CDx, Expanding PSMA-PET Imaging Access FDA Accepts Telix's NDA for TLX007-CDx, Expanding PSMA-PET Imaging Access psma petfdaacceptsndacdx https://avesis.gazi.edu.tr/publication/details/9008146e-0796-4f19-95f3-44f0272af7e5/factors-affecting-diagnostic-performance-of-ga-68-psma-pet-mri-in-biochemical-recurrent-prostate-cancer-and-nomogram-model Factors Affecting Diagnostic Performance of Ga-68 PSMA PET/MRI in Biochemical Recurrent Prostate... factors affectingpsma petdiagnosticperformancega https://portal.fis.tum.de/en/publications/the-value-of-tumor-markers-in-men-with-metastatic-prostate-cancer/ The value of tumor markers in men with metastatic prostate cancer undergoing [177Lu]Lu-PSMA... metastatic prostate cancerthe valuetumor markersin menpsma https://researchprofiles.herts.ac.uk/en/publications/is-there-a-role-of-psma-pet-in-focal-therapy-planning-and-follow-/ Is there a role of PSMA-PET in focal therapy planning and follow-up? Clinical - University of... role ofpsma petfocal therapyfollow upplanning https://www.helios-gesundheit.de/standorte-angebote/kliniken/krefeld/news/2024/psma-therapie-bei-prostatakrebs/ PSMA-Therapie bei Prostatakrebs Neues Verfahren beim Prostatakarzinom mit Lutetium177. Erfahren Sie hier mehr zur PSMA-Therapie am Prostatakrebszentrum Krefeld. therapie bei prostatakrebspsma https://studylib.net/doc/5545672/view-and-psma-information-presentation. View and PSMA Information Presentation. Free essays, homework help, flashcards, research papers, book reports, term papers, history, science, politics viewpsmainformationpresentation https://www.bdbiosciences.com/en-ca/products/reagents/flow-cytometry-reagents/research-reagents/single-color-antibodies-ruo/rb545-mouse-anti-human-psma.756766 RB545 Mouse Anti-Human PSMA The 107-1A4 monoclonal antibody specifically recognizes human Prostate-Specific Membrane Antigen (PSMA) which is also known as Glutamate carboxypeptidase II... mouseantihumanpsma https://www.cancer.columbia.edu/cancer-types-care/clinical-trials/find-clinical-trial/phase-1-study-jnj-87189401-psma-cd28-bispecific-antibody-combined-jnj-78278343-klk2-cd3-bispecific-antibody-advanced-prostate-cancer A Phase 1 Study of JNJ-87189401 (PSMA-CD28 Bispecific Antibody) Combined with JNJ 78278343... May 25, 2025 - The purpose of this study is to find out the side effects of JNJ-87189401 given in combination with JNJ-78278343 to patients with metastatic... bispecific antibodyphasestudyjnjpsma https://connect.mayoclinic.org/comment/1427651/replies/ Replies to @whatthef Wow, I never heard this. I did have the PET CT F-18 PSMA DCFPyL (PYLARIFY)....... View direct replies to @whatthef Wow, I never heard this. I did have the PET CT F-18 PSMA DCFPyL (PYLARIFY).... i neverpet ctreplieswowheard https://scholars.aku.edu/en/publications/diagnostic-challenges-in-prostate-cancer-and-sup68supga-psma-pet-/ Diagnostic challenges in prostate cancer and 68Ga-PSMA PET imaging: A game changer? - The Aga... prostate cancerpsma petgame changerdiagnosticchallenges https://www.allclinicaltrials.com/study/NCT06235151 Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer pet imagingnewly diagnosedprostate cancercoppercu https://www.spierziekten.nl/nieuws/mensen-met-als-of-psma-gevraagd-voor-interview/ Mensen met ALS of PSMA gevraagd voor interview - Spierziekten Mar 24, 2025 - Mensen met ALS of PSMA gevraagd voor interview mensenmetalspsmagevraagd https://umcutrecht.nl/nl/behandeling/behandeling-prostaatkanker-met-lutetium-177-psma Behandeling prostaatkanker met Lutetium-177-PSMA - UMC Utrecht Behandeling prostaatkanker met Lutetium-177-PSMA behandeling prostaatkankerumc utrechtmetlutetiumpsma https://www.kucancercenter.org/cancer-clinical-trials/find-trial/clinical-trial-results/study00160365 A Phase III, Multi-center, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA... phase iiimulticenteropenlabel https://researchexperts.utmb.edu/en/publications/prostate-cancer-brain-metastases-monitoring-response-to-treatment/fingerprints/ Prostate cancer brain metastases: Monitoring response to treatment with PSMA PET/CT - Fingerprint -... prostate cancerbrain metastasespsma petmonitoringresponse https://www.psmavancouver.com/ PSMA Vancouver Building professionals building professionals. Learn and play with people working on the built environment in southwest British Columbia, Canada. psmavancouver https://science.rsu.lv/en/datasets/recurrent-prostate-cancer-diagnostic-with-68ga-psma-11-petct/ Recurrent prostate cancer diagnostic with 68Ga-PSMA-11 PET/CT - RSU recurrent prostate cancerpet ctdiagnosticpsmarsu https://www.mblbio.com/bio/g/dtl/T/?pcd=TC-0161-1 HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-PE | Class I | MBL Life Sience -GLOBAL- @@@extension:TetramerProductDescriptionGL(product_cd=TC-0161-1::prev=)@@@ class ihlapsmapembl https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voxalatamab Definition of anti-PSMA/CD3 bispecific antibody JNJ-63898081 - NCI Drug Dictionary - NCI Find technical definitions and synonyms by letter for drugs/agents used to treat patients with cancer or conditions related to cancer. Each entry includes... bispecific antibodydrug dictionarydefinitionpsmajnj https://aap.com.au/aapreleases/cision20250909ae69289/ Telix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis |... psma petprostate cancerdosesfirstpatient https://www.pcf.org/our-work/the-work-we-fund/creativity-awards/class-of-2011/evaluation-of-psma-based-pet/ PSMA PET Imaging Biomarker: Steve Cho, MD | PCF Mar 12, 2026 - Evaluation of PSMA-based PET as Functional Imaging Biomarker of Primary Prostate Cancer Steve Cho, MDAssistant Professor of RadiologyThe Johns Hopkins psma petimagingbiomarkerstevecho https://research.uni-luebeck.de/de/publications/sup68supga-psma-petct-imaging-predicting-intraprostatic-tumor-ext/ 68Ga-PSMA PET/CT Imaging Predicting Intraprostatic Tumor Extent, Extracapsular Extension and... psma petct imagingtumorextentextension https://scholars.nova.edu/en/publications/quantifying-radiosensitization-of-psma-targeted-gold-nanoparticle/ Quantifying Radiosensitization of PSMA-Targeted Gold Nanoparticles on Prostate Cancer Cells at... gold nanoparticlesprostate cancerpsmatargetedcells https://adisinsight.springer.com/trials/700305726?error=cookies_not_supported&code=2afb4e80-8a6a-4878-9702-27ac300bf7f2 Clinical observations with doses of 4, 6, 7.4, and 9.3 GBq of 177Lu-PSMA-617 repeated every 2 month... The aim of this retrospective analysis was to report clinical experience with doses of 4, 6, 7.4, and 9.3 GBq of 177Lu-PSMA-617 repeated every 2 month. clinicalobservationsdosespsmarepeated https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials/clinical-trials-index/clinical-trials-detail.ID2023-0135.html A pilot presurgical trial of REGN5678 (Anti-PSMA x CD28) in patients with high-risk, localized... To learn about the safety and effects of a drug called REGN5678 when it is given to patients with high-risk prostate cancer. in patientshigh riskpilottrialanti